Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. DPZ
4. ACN
5. IBM
6. META
7. PLTR
8. MSFT
9. MHTLY
10. NAVN

Go back to Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
COGENT (NASDAQ: COGT) Delayed: 35.84 --0 (-0%)
Previous Close $35.84    52 Week High $5.57 
Open $35.84    52 Week Low $2.90 
Day High $35.84    P/E 162.91 
Day Low $35.84    EPS $0.22 
Volume 368